- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2377
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Amyloid and tau cerebrospinal fluid biomarkers in HIV infection ; volume:9 ; number:1 ; day:22 ; month:12 ; year:2009 ; pages:1-13 ; date:12.2009
BMC neurology ; 9, Heft 1 (22.12.2009), 1-13, 12.2009
- Urheber
-
Gisslén, Magnus
- Beteiligte Personen und Organisationen
-
Krut, Jan
Andréasson, Ulf
Blennow, Kaj
Cinque, Paola
Brew, Bruce J.
Spudich, Serena
Hagberg, Lars
Rosengren, Lars
Price, Richard W.
Zetterberg, Henrik
SpringerLink (Online service)
- DOI
-
10.1186/1471-2377-9-63
- URN
-
urn:nbn:de:1111-2016030326905
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
16.04.0007, 08:38 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gisslén, Magnus
- Krut, Jan
- Andréasson, Ulf
- Blennow, Kaj
- Cinque, Paola
- Brew, Bruce J.
- Spudich, Serena
- Hagberg, Lars
- Rosengren, Lars
- Price, Richard W.
- Zetterberg, Henrik
- SpringerLink (Online service)
Ähnliche Objekte (12)
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Fluid biomarkers in Alzheimer’s disease – current concepts
Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Fluid biomarkers in Alzheimer’s disease – current concepts
Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications
Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer’s disease from subjective cognitive decline and other dementias
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Fluid biomarkers in Alzheimer’s disease – current concepts
Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications